Show simple item record

dc.contributor.authorRocha, Sara
dc.contributor.authorVieira, Jorge
dc.contributor.authorVázquez González, Noé
dc.contributor.authorLópez Fernández, Hugo 
dc.contributor.authorFernández Riverola, Florentino 
dc.contributor.authorReboiro Jato, Miguel 
dc.contributor.authorSousa, André D.
dc.contributor.authorVieira, Cristina P.
dc.date.accessioned2022-11-28T13:17:13Z
dc.date.available2022-11-28T13:17:13Z
dc.date.issued2019-10-26
dc.identifier.citationBMC Medical Genomics, 12(1): 145 (2019)spa
dc.identifier.issn17558794
dc.identifier.urihttp://hdl.handle.net/11093/4169
dc.description.abstractBackground Wild-type (wt) polyglutamine (polyQ) regions are implicated in stabilization of protein-protein interactions (PPI). Pathological polyQ expansion, such as that in human Ataxin-1 (ATXN1), that causes spinocerebellar ataxia type 1 (SCA1), results in abnormal PPI. For ATXN1 a larger number of interactors has been reported for the expanded (82Q) than the wt (29Q) protein. Methods To understand how the expanded polyQ affects PPI, protein structures were predicted for wt and expanded ATXN1, as well as, for 71 ATXN1 interactors. Then, the binding surfaces of wt and expanded ATXN1 with the reported interactors were inferred. Results Our data supports that the polyQ expansion alters the ATXN1 conformation and that it enhances the strength of interaction with ATXN1 partners. For both ATXN1 variants, the number of residues at the predicted binding interface are greater after the polyQ, mainly due to the AXH domain. Moreover, the difference in the interaction strength of the ATXN1 variants was due to an increase in the number of interactions at the N-terminal region, before the polyQ, for the expanded form. Conclusions There are three regions at the AXH domain that are essential for ATXN1 PPI. The N-terminal region is responsible for the strength of the PPI with the ATXN1 variants. How the predicted motifs in this region affect PPI is discussed, in the context of ATXN1 post-transcriptional modifications.en
dc.description.sponsorshipXunta de Galicia | Ref. ED481B 2016/068–0spa
dc.description.sponsorshipXunta de Galicia | Ref. ED431C2018/55-GRCspa
dc.description.sponsorshipFEDER | Ref. Norte-01-0145-FEDER-000008spa
dc.language.isoengspa
dc.publisherBMC Medical Genomicsspa
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleATXN1 N-terminal region explains the binding differences of wild-type and expanded formsen
dc.typearticlespa
dc.rights.accessRightsopenAccessspa
dc.identifier.doi10.1186/s12920-019-0594-4
dc.identifier.editorhttps://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-019-0594-4spa
dc.publisher.departamentoInformáticaspa
dc.publisher.grupoinvestigacionSistemas Informáticos de Nova Xeraciónspa
dc.subject.unesco32 Ciencias Médicasspa
dc.subject.unesco2302.27 Proteínasspa
dc.subject.unesco2410.07 Genética Humanaspa
dc.date.updated2022-11-25T11:58:55Z
dc.computerCitationpub_title=BMC Medical Genomics|volume=12|journal_number=1|start_pag=145|end_pag=spa


Files in this item

[PDF]

    Show simple item record

    Attribution 4.0 International
    Except where otherwise noted, this item's license is described as Attribution 4.0 International